Skip to content

Raj Patel

NPI 1457710980ActiveIndividual· Internal Medicine, Infectious Disease· Irvington, NJ

Internal Medicine, Infectious Disease with Hemant G Patel MD PA, practicing in Irvington, New Jersey. Their prescriptions cost Medicare Part D more than their services did: $2,423,028 for 10,820 claims, against $227,359 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 13 companies reporting payments in 2025, $1,193 in all, mostly food and beverage. Lists Cooperman Barnabas Medical Center and 2 other hospitals as hospital affiliations.

Overview

NPI1457710980
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedFeb 11, 2016
Last updated in NPPESApr 9, 2018

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Infectious Disease Primary207RI0200X25MA10303200NJ

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Infectious Disease (NJ)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients513
Services billed2,767 across 22 procedure codes
Paid by Medicare$227,359

Part D prescriptions in 2024

Prescriptions (claims)10,820 · 23,343 30-day fills
Patients793
Total drug cost$2,423,028
Generic share83% of claims

Medicare sources and data years

Education and affiliations

Graduation year2012
Medicare specialtyInfectious Disease

Medical group

Hospital affiliations

Other facilities

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,193 · 71 payments from 13 companies
  • 2024$204.35 · 13 payments from 8 companies

Top paying companies in 2025

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$249.8221
Novo Nordisk Inc$240.7511
Gilead Sciences, Inc.$218.8416
Insmed, Inc.$138.599
Si-Bone, Inc.$130.932

What the 2025 payments were for

  • Food and Beverage$1,193 · 71 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records